- Report
- January 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- April 2023
- 116 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2023
- 160 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- January 2024
- 194 Pages
Global
€4767EUR$4,995USD£3,994GBP
- Report
- March 2023
- 408 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- March 2023
- 136 Pages
Middle East, Africa
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2023
- 136 Pages
Asia Pacific
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2023
- 135 Pages
Europe
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2023
- 110 Pages
North America
From €1432EUR$1,500USD£1,199GBP
- Report
- February 2024
- 89 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- October 2023
- 10 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- July 2022
- 9 Pages
Global
From €3006EUR$3,150USD£2,519GBP

The Neurovascular Device market is a subset of the Neurology Devices market, which focuses on the diagnosis and treatment of neurological disorders. Neurovascular Devices are used to treat conditions such as stroke, aneurysms, and arteriovenous malformations. These devices are used to restore blood flow to the brain, reduce the risk of stroke, and improve patient outcomes. Neurovascular Devices include stents, embolic coils, flow diverters, and occlusion balloons. These devices are used in a variety of procedures, such as endovascular coiling, stenting, and thrombectomy.
Some of the major companies in the Neurovascular Device market include Medtronic, Johnson & Johnson, Stryker, Boston Scientific, and Terumo. Other companies include Penumbra, MicroPort Scientific, Merit Medical, and W.L. Gore & Associates. Show Less Read more